Pivotal Bio Venture Partners Investment Advisor LLC Iterum Therapeutics PLC Transaction History

Pivotal Bio Venture Partners Investment Advisor LLC

  • $111 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$0.97 - $2.73 $916,732 - $2.58 Million
-945,085 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$0.46 - $1.2 $434,739 - $1.13 Million
945,085 New
945,085 $935,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $15.9M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email